|
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 23.50 USD | +0.09% |
|
-.--% | +159.10% |
| 17/06 | Assertio Holdings Completes Merger With Zydus Lifesciences | MT |
| 17/06 | Assertio Holdings, Inc. Announces Board and Committee Changes, Effective June 16, 2026 | CI |
| Market Cap | 152M 132M 123M 113M 213M 14.47B 217M 1.45B 569M 7.22B 570M 558M 23.81B | P/E 2027 * |
-
| P/E 2028 * | - |
|---|---|---|---|---|---|
| Enterprise Value | 129M 112M 104M 95.87M 181M 12.27B 184M 1.23B 482M 6.12B 483M 473M 20.18B | EV / Sales 2027 * |
-
| EV / Sales 2028 * | - |
| Free-Float |
98.57% | Yield 2027 * |
-
| Yield 2028 * | - |
Last Transcript: Assertio Holdings
| 1 day | +0.09% | ||
| 3 months | +27.23% | ||
| 6 months | +91.99% | ||
| Current year | +159.10% |
| Current year | 9.11 |  | 23.5 |
| 1 year | 8.61 | | 23.5 |
| 3 years | 7.71 | | 55.58 |
| 5 years | 7.71 | | 120.15 |
| 10 years | 7.71 | | 1,621.19 |
| Director | Title | Age | Since |
|---|---|---|---|
Ravi Yadavar
BRD | Director/Board Member | 26 | 16/06/2026 |
Punit Patel
BRD | Director/Board Member | - | 16/06/2026 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 5/5/26 | Free | Director | 4,851 | 0.0753% | ||
| 2/3/26 | Free | Chief Financial Officer | 39,932 | 0.6223% | ||
| 21/2/26 | Fiscal year | Chairperson | 2,852 | 0.0444% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +0.09% | -.--% | +119.88% | -71.04% | 152M | |
| -2.69% | -6.82% | +45.11% | +148.43% | 1,024B | |
| -1.19% | -4.99% | +47.73% | +48.08% | 618B | |
| -1.53% | -4.33% | +24.65% | +64.91% | 443B | |
| +0.68% | -1.14% | +39.61% | +33.36% | 349B | |
| -1.66% | -3.13% | +31.63% | +39.79% | 297B | |
| -8.96% | -10.77% | +3.27% | +5.50% | 264B | |
| -1.37% | -7.41% | -3.42% | -43.67% | 209B | |
| -1.78% | +0.81% | +25.62% | +64.41% | 208B | |
| -0.36% | -0.48% | +13.44% | +71.98% | 162B | |
| Average | -1.87% | -1.18% | +34.75% | +36.18% | 357.39B | |
| Weighted average by Cap. | -2.09% | -2.17% | +32.88% | +70.34% |
| 2027 * | 2028 * | |
|---|---|---|
| Net sales | - | - |
| Net income | 400K 348K 325K 298K 562K 38.13M 572K 3.83M 1.5M 19.01M 1.5M 1.47M 62.71M | - |
| Net Debt | - | - |
Employees
53
Sector
Pharmaceuticals
- Stock Market
- Stocks
- ASRT Stock
Select your edition
All financial news and data tailored to specific country editions
